Literature DB >> 23752055

FDA panel advises easing restrictions on rosiglitazone.

Miriam E Tucker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23752055     DOI: 10.1136/bmj.f3769

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes.

Authors:  Avivit Cahn; Simona Cernea; Itamar Raz
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

2.  Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.

Authors:  Richard M Turner; Chun S Kwok; Chen Chen-Turner; Chinedu A Maduakor; Sonal Singh; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

3.  Chronic stress and Rosiglitazone increase indices of vascular stiffness in male rats.

Authors:  M L Goodson; A E B Packard; D R Buesing; M Maney; B Myers; Y Fang; J E Basford; D Y Hui; Y M Ulrich-Lai; J P Herman; Karen K Ryan
Journal:  Physiol Behav       Date:  2016-03-31

4.  Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center.

Authors:  M Constantine Samaan; Marlie Valencia; Connie Cheung; Boguslaw Wilk; Keith Lau; Lehana Thabane
Journal:  J Multidiscip Healthc       Date:  2014-07-31

Review 5.  Management of pediatric and adolescent type 2 diabetes.

Authors:  M Constantine Samaan
Journal:  Int J Pediatr       Date:  2013-10-23

Review 6.  The use of expensive technologies instead of simple, sound and effective lifestyle interventions: a perpetual delusion.

Authors:  Silvia Carlos; Jokin de Irala; Matt Hanley; Miguel Ángel Martínez-González
Journal:  J Epidemiol Community Health       Date:  2014-06-24       Impact factor: 3.710

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.